Semaglutide's Multi-Organ Benefits in Type 2 Diabetes Stem from Broad Molecular Adaptations Across Inflammatory, Lipid, and ECM Pathways
The systems medicine view of semaglutide: from clinical trials to molecular mechanisms.
Abstract
A comprehensive review details how semaglutide improves glycemic control, weight, and cardiovascular health by modulating inflammatory, lipid, and extracellular matrix pathways.